The treatment of early breast cancer in women over the age of 70
Open Access
- 21 June 2011
- journal article
- research article
- Published by Springer Nature in British Journal of Cancer
- Vol. 105 (2) , 189-193
Abstract
One third of all breast cancers are diagnosed in women aged 70 or over. Older women are a heterogeneous population who are under-represented in clinical trials, and as a result uncertainty can exist as to what represents optimal treatment. This minireview, from an international authorship, summarises the existing evidence surrounding the management of early breast cancer in women aged 70 and over. The use of primary surgery and endocrine therapy, and adjuvant chemotherapy, radiotherapy, endocrine therapy and trastuzumab are discussed. Reference is made to ongoing clinical trials in this area and areas of controversy are highlighted.Keywords
This publication has 30 references indexed in Scilit:
- Breast Cancer Among the Oldest Old: Tumor Characteristics, Treatment Choices, and SurvivalJournal of Clinical Oncology, 2010
- Adjuvant Chemotherapy in Older Women with Early-Stage Breast CancerNew England Journal of Medicine, 2009
- The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trialThe Lancet, 2008
- Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 100-month analysis of the ATAC trialThe Lancet Oncology, 2008
- The role of surgery in the management of older women with breast cancerEuropean Journal of Cancer, 2007
- Non-standard management of breast cancer increases with age in the UK: a population based cohort of women ⩾65 yearsBritish Journal of Cancer, 2007
- Trastuzumab after adjuvant chemotherapy in older patients – Authors' replyThe Lancet, 2007
- Surgery, with or without tamoxifen, vs tamoxifen alone for older women with operable breast cancer: Cochrane reviewBritish Journal of Cancer, 2007
- Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trialsThe Lancet, 2005
- Randomized Trial of Dose-Dense Versus Conventionally Scheduled and Sequential Versus Concurrent Combination Chemotherapy as Postoperative Adjuvant Treatment of Node-Positive Primary Breast Cancer: First Report of Intergroup Trial C9741/Cancer and Leukemia Group B Trial 9741Journal of Clinical Oncology, 2003